Company Overview of Tioga Pharmaceuticals, Inc.
Tioga Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing novel therapies for the treatment of pruritus. It is involved in the Phase-2 clinical study of Asimadoline, an orally active highly selective kappa-opioid receptor specific agonist for the treatment of pruritus or itching associated with atopic dermatitis. The company was founded in 2005 and is based in San Diego, California.
4747 Executive Drive
San Diego, CA 92121
Founded in 2005
Key Executives for Tioga Pharmaceuticals, Inc.
Tioga Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Tioga Pharmaceuticals, Inc., please visit www.tiogapharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.